Syneos Health, Inc. Share Price
Equities
SYNH
US87166B1026
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
Colin Shannon
CEO | Chief Executive Officer | 65 | 28/23/28 |
Michael Bonello
DFI | Director of Finance/CFO | 55 | 01/23/01 |
Michael Brooks
COO | Chief Operating Officer | 50 | 14/21/14 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Momtazee
BRD | Director/Board Member | 52 | 28/23/28 |
Colin Shannon
CEO | Chief Executive Officer | 65 | 28/23/28 |
James Dimitri
BRD | Director/Board Member | - | 28/23/28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.82% | 8 M€ | +2.44% | ||
0.77% | 2 M€ | +6.77% | ||
0.50% | 0 M€ | 0.00% | - | |
0.36% | 0 M€ | 0.00% | - |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |